The Testosterone Debate: Decoded

500 Seats. Sold Out!

We knew this one would fill fast.

When you put Dr. Kelly Casperson in a room to break down what women told the FDA about testosterone access? People show up.

The live session is full. But we planned for this, and the replay is coming. Waitlist members get first access at the lowest price.

Here's the Deal

The moment the replay goes live, waitlist members get a 48-hour window to grab it at $27.

After that? It goes to $45 and stays there.

This is the only way to get it at the lower price. So if you want it, get on the list.

What You'll Actually Get

This isn't a summary. It's a full 60-minute breakdown with Kelly, including:

- The 7 dominant themes women raised in the FDA comment period
- What "off-label" actually means (and why it's not what you think)
- The regulatory realities that shape who gets access and who doesn't
- Where the safety fears are real, and where they're overblown
- What this moment signals for women and testosterone moving forward

Plus the full live Q&A, uncut.